SITE MAP 
  HOME  
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
  JOBS  
  FREE SUBSCRIPTION  
  Tuesday, May 13, 2008 SEARCH     
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND

New Zealand Pharma and Biotech Companies
PRIME NEWS
Field trials show no environmental impact of gene transfer in NZ
New Zealand's most comprehensive, independent scientific field trial of genetically modified trees has been completed, with results showing no environmental impact from the trial and no evidence of gene transfer to other organisms
Living Cell Technologies to list on International OTCQX
Living Cell Technologies has applied to list its ADR program on the International OTCQX to increase the Companys exposure to US investors
TODAY'S NEWS
  Aurobindo Pharma to market 9 products in South Africa
  Spectrum Pharma sells injectable generic drugs to Sagent Pharma
  Merck, Schering-Plough present results of cholesterol drug
  Ranbaxy, Merck sign drug discovery, development agreement
  Over 1200 firms attend API & INTERPHEX China
  Helicon group secures China rights For Collatamp G

BioSpectrum New Zealand is a specialized information pool for NewZealand pharma and bio technology articles. It provides latest coverage in the areas of Newzealand biotech industry, bio technology company, New Zealand Pharma Companies.
Advertisement
 
Digital Mag
Updated Fortnightly

Issue: April 30, 2008
Current Issue
View / Download
Top Story
China steps up the pace: India and China are racing to become lucrative pharmaceutical markets for global players
 
 
 
Print Edition
Issue: May 2008
Read Online
Free Subscription
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement





















 

NEWS
Living Cell Technologies to list on International OTCQX
Living Cell Technologies has applied to list its ADR program on the International OTCQX to increase the Companys exposure to US investors
CBI, NZ Pharma in drug discovery pact
US-based Commonwealth Biotechnologies has entered into a global strategic alliance with New Zealand Pharmaceuticals to provide a suite of small molecule chemistry products for the drug discovery and development market
FEATURES
Peter Bradley: Securacell is our first success
KODE Biotech Limited specializes in research into the biomedical applications. In an interview with BioSpectrum, CEO Mr Peter Bradley shares the recent success KODE has had with its proprietary KODE technology platform
New Zealand: A destination of choice
China, South Korea and Japan account for over half of the foreign students in New Zealand
PEOPLE
AgResearch mathematician wins NZBio award
Dr Paul Shorten,a scientist from AgResearch, New Zealand's largest Crown Research Institute has won the prestigious NZBio Emerging Biotechnologist of the Year award
Ms Bronwyn Dilley is NZBio CEO
New Zealand's Biotech Industry Organization (NZBio) announced the appointment of Ms Bronwyn Dilley to the position of Chief Executive Officer, effective immediately
EVENTS
New Zealand pitches for top biotech slot
New Zealand is all set to lay the foundations for taking the top slot at the global biotech table but with a careful approach to suit its unique environment, said the country's Minister for Research, Science and Technology, Mr Steve Maharey
R & D
Field trials show no environmental impact of gene transfer in NZ
New Zealand's most comprehensive, independent scientific field trial of genetically modified trees has been completed, with results showing no environmental impact from the trial and no evidence of gene transfer to other organisms
Platypus genome mapping boon for human and livestock researchers
In decoding the genome of the platypus, a team of researchers from the US, Australia, England, Germany, Israel, Japan, Spain and New Zealand has revealed important information that will enhance the understanding of other mammals
POLICIES
New Zealand comes up with new tax credit initiative
To help increase the level of private research and development, the Government of New Zealand has come up with new tax credit initiative which comes into effect from April 1. Under this initiative, businesses investing in R&D can earn 15% tax credit
New Zealand in science pact with US
New Zealand has entered into a science pact with the US to identify opportunities to support the development of competitiveness and economic sustainability of the both the countries
PRODUCTS
Angiotech launches Zilver PTX drug-eluting stent in New Zealand
Angiotech Pharmaceuticals, a global specialty pharmaceutical and medical device company based out of Vancouver announced that the first New Zealand patient was treated with Cook Medicals Zilver PTX drug-eluting peripheral stent
Merck Sharp introduces JANUVIA for type 2 diabetes in New Zealand
New Zealanders with type 2 diabetes now have access to a new medicine which is significantly less likely to cause weight gain or dangerously low blood sugar; thanks to Merck Sharp & Dohme New Zealand's (MSDNZ) once-daily tablet, JANUVIA
TRENDS & ANALYSIS
Biotech spreading across all regions in New Zealand
Twenty-one percent of biotechnology organizations are active in the Auckland region, but biotechnology activity is spread evenly across the remainder of the country, according to the Statistics New Zealand
 
Advertisement





 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[CIOL Shop]  [DQ Channels]  [The DQweek]  [CyberMedia Dice]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black